Table 4.
Clinical characteristics of the ACS patients and control group.
| Characteristic [Clinical Standards] |
Control Group (n = 12) |
Study Group (ACS) (n = 12) |
|---|---|---|
| Age | 55 ± 6.61 | 57 ± 11 (p = 0.100; n.s.) |
| Gender (M/F) | M8/F4 | M8/F4 |
| BMI [<30] | 26.40 ± 6.61 | 21.9 ± 4.85 (p = 0.413; n.s.) |
| Triglycerides [<2.5 mmol/L] | 1.18 ± 0.54 | 2.17 ± 0.82 (p = 0.005) |
| Total cholesterol [3–5 mmol/L] | 4.02 ± 1.34 | 4.68 ± 1.12 (p = 0.196; n.s.) |
| HDL [>1 mmol/L] | 1.31 ± 0.53 | 1.17 ± 0.21 (p = 0.700; n.s.) |
| LDL [<2.9 mmol/L] | 2.89 ± 1.09 | 1.54 ± 0.97 (p = 0.413; n.s.) |
| Leukocytes on admission [4–11 × 103/μL] |
7.78 ± 2.52 | 9.63 ± 2.42 (p = 0.027) |
| Erythrocytes on admission [4–6 × 106/μL] |
5.08 ± 0.41 | 4.72 ± 0.66 (p = 0.118) |
| Platelets on admission [150–400 × 103/μL] |
316.17 ± 119.70 | 242.3 ± 87.2 (p = 0.098; n.s.) |
| Creatinine [64–104 μmol/L] | 83.94 ± 15.70 | 84.25 ± 14.01 (p = 0.960; n.s.) |
| Troponin peak (hs-TnT) [<14 ng/L] | 13.34 ± 0.23 | 2778 ± 2361.33 (p = 0.0005) |
| ALT [0–45 UI] | 23.92 ± 12.80 | 30.07 ± 13.18 (p = 0.259) |
| AST [0–35 UI] | 21.30 ± 7.12 | 33.44 ± 15.07 (p = 0.019) |
| Glucose [4.1–5.5 mmol/L] | 5.07 ± 0.60 | 5.40 ± 0.44 (p = 0.131) |
| GFR [ml/min./1.73 m2] | 94 ± 14 | 93 ± 9 (p = 0.735) |
| NSTEMI/STEMI | - | 4/8 |
| Localization of culprit lesion | - | Cx (n = 5); RCA (n = 4); LCA (n = 1); LAD (n = 2) |
| Statins administration | - | Patients before admission to hospital were not treated with statins. All patients received first dose of statin (at least 20 mg dose of Rosuvastatin) during the first 24 h of ACS. |
Abbreviations: ALT–alanine transaminase; AST–aspartate transaminase; BMI–body mass index; Cx–circumflex artery; F–female; GFR–glomerular filtration rate; HDL–high-density lipoprotein; hs-TnT–high-sensitivity troponin T; LAD–left ante-rior descending artery; LCA–left main coronary artery; LDL–low-density lipopro-tein; M–male; NSTEMI–non-ST-elevation myocardial infarction; RCA–right coronary artery; STEMI–ST-elevation myocardial infarction. Statistically significant p-values (p < 0.05) are marked in bold.